HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nephrin is expressed on the surface of insulin vesicles and facilitates glucose-stimulated insulin release.

AbstractOBJECTIVE:
Nephrin, an immunoglobulin-like protein essential for the function of the glomerular podocyte and regulated in diabetic nephropathy, is also expressed in pancreatic beta-cells, where its function remains unknown. The aim of this study was to investigate whether diabetes modulates nephrin expression in human pancreatic islets and to explore the role of nephrin in beta-cell function.
RESEARCH DESIGN AND METHODS:
Nephrin expression in human pancreas and in MIN6 insulinoma cells was studied by Western blot, PCR, confocal microscopy, subcellular fractionation, and immunogold labeling. Islets from diabetic (n = 5) and nondiabetic (n = 7) patients were compared. Stable transfection and siRNA knockdown in MIN-6 cells/human islets were used to study nephrin function in vitro and in vivo after transplantation in diabetic immunodeficient mice. Live imaging of green fluorescent protein (GFP)-nephrin-transfected cells was used to study nephrin endocytosis.
RESULTS:
Nephrin was found at the plasma membrane and on insulin vesicles. Nephrin expression was decreased in islets from diabetic patients when compared with nondiabetic control subjects. Nephrin transfection in MIN-6 cells/pseudoislets resulted in higher glucose-stimulated insulin release in vitro and in vivo after transplantation into immunodeficient diabetic mice. Nephrin gene silencing abolished stimulated insulin release. Confocal imaging of GFP-nephrin-transfected cells revealed nephrin endocytosis upon glucose stimulation. Actin stabilization prevented nephrin trafficking as well as nephrin-positive effect on insulin release.
CONCLUSIONS:
Our data suggest that nephrin is an active component of insulin vesicle machinery that may affect vesicle-actin interaction and mobilization to the plasma membrane. Development of drugs targeting nephrin may represent a novel approach to treat diabetes.
AuthorsAlessia Fornoni, Jongmin Jeon, Javier Varona Santos, Lorenzo Cobianchi, Alexandra Jauregui, Luca Inverardi, Slavena A Mandic, Christina Bark, Kevin Johnson, George McNamara, Antonello Pileggi, R Damaris Molano, Jochen Reiser, Karl Tryggvason, Dontscho Kerjaschki, Per-Olof Berggren, Peter Mundel, Camillo Ricordi
JournalDiabetes (Diabetes) Vol. 59 Issue 1 Pg. 190-9 (Jan 2010) ISSN: 1939-327X [Electronic] United States
PMID19833886 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA Primers
  • Insulin
  • Membrane Proteins
  • RNA, Small Interfering
  • nephrin
  • Glucose
Topics
  • Animals
  • Cell Membrane (physiology)
  • DNA Primers
  • Diabetes Mellitus (genetics)
  • Diabetes Mellitus, Experimental (genetics, immunology)
  • Gene Expression Regulation
  • Glucose (pharmacology)
  • Humans
  • Insulin (metabolism)
  • Insulin Secretion
  • Islets of Langerhans (physiology)
  • Islets of Langerhans Transplantation
  • Membrane Proteins (genetics)
  • Mice
  • Polymerase Chain Reaction
  • RNA, Small Interfering (genetics)
  • Reference Values
  • Transfection
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: